|
|
| Name of Committee | Circulatory System Devices Panel |
| Date and Time | The meeting was held on the following dates:
Dec 5, 02 9:00 AM - 5:00 PM
|
| Location | Hilton Washington DC North/Gaithersburg, Salon A, 620 Perry Parkway
Gaithersburd
, MD |
| Contact Information | Geretta Wood, Center for Devices and Radiological Health (HFZ-450), Food and Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850 Information can be found on the FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512625. Please call the Information Line or access this Internet page for up-to-date information on this meeting. |
| Procedure | On December 5, 2002, from 9 a.m. to 10 a.m., the meeting is open to the public. Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person by November 30, 2002. Oral presentations from the public will be scheduled between approximately 9 a.m. and 10 a.m. Time allotted for each presentation may be limited. Those desiring to make formal oral presentations should notify the contact person before November 30, 2002 and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation. |
| Closed Committee Information | On December 5, 2002, from 10 a.m. to 5 p.m., the meeting will be closed to the public. The committee will hear and review trade secret and/or confidential commercial information presented by a sponsor. This portion of the meeting will be closed to permit discussion of this information (5 U.S.C. 552b(c)(4)). Persons attending FDA's advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets. |
| Conduct | FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site at http://www.fda.gov/oc/advisory/ for procedures on public conduct during advisory committee meetings. |
| Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). |
|
